• editor.aipublications@gmail.com
  • Track Your Paper
  • Contact Us
  • ISSN: 2456-8015

International Journal Of Medical, Pharmacy And Drug Research(IJMPD)

Peptic Ulcer: A review

Karanvir Singh , Rajesh Kumar , Ajeet Pal Singh , Meenakshi Malhotra , Amar Pal Singh , Ritu Rani


International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-8,Issue-2, April - June 2024, Pages 38-46 , 10.22161/ijmpd.8.2.5

Download | Downloads : 27 | Total View : 8543

Article Info: Received: 09 Mar 2024; Received in revised form:25 Apr 2024; Accepted:05 May 2024; Available online: 13 May 2024

Share

Peptic ulcers, characterized by painful sores that develop on the lining of the stomach, small intestine, or esophagus, are a prevalent gastrointestinal condition affecting millions worldwide. This abstract provides an overview of the causes, symptoms, and treatment options for peptic ulcers. Peptic ulcers primarily stem from the imbalance between aggressive factors such as gastric acid secretion, pepsin, and Helicobacter pylori infection, and defensive mechanisms like mucosal barrier integrity and blood flow. Lifestyle factors such as excessive alcohol consumption, smoking, and stress, along with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), also contribute to ulcer formation. Symptoms of peptic ulcers include burning pain in the abdomen, bloating, nausea, vomiting, and unintended weight loss. However, some individuals may remain asymptomatic or experience atypical symptoms. Diagnosis typically involves a combination of medical history assessment, physical examination, and diagnostic tests such as endoscopy, barium X-ray, and H. pylori testing. Treatment aims to alleviate symptoms, promote ulcer healing, and prevent recurrence. Proton pump inhibitors (PPIs), histamine receptor antagonists (H2RAs), and antibiotics are commonly prescribed to reduce gastric acid secretion, eradicate H. pylori infection, and promote ulcer healing. Lifestyle modifications including dietary changes, stress reduction techniques, and cessation of smoking and alcohol consumption are also integral components of ulcer management. In conclusion, peptic ulcers are a common gastrointestinal disorder with multifactorial etiology. Early recognition of symptoms, accurate diagnosis, and prompt initiation of appropriate treatment are essential to prevent complications and improve patient outcomes.

Peptic ulcers, Gastrointestinal condition, Helicobacter pylori, Diagnosis, Treatment options

[1] Lanas, A., Chan, F. K., & Peptic Ulcer Bleed Study Group. (2011). Peptic ulcer disease. The Lancet, 378(9800), 173-184.
[2] Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., ... & Graham, D. Y. (2017). Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut, 66(1), 6-30.
[3] Moayyedi, P., Lacy, B. E., Andrews, C. N., Enns, R. A., Howden, C. W., Vakil, N., ... & Quigley, E. M. M. (2017). ACG and CAG Clinical Guideline: Management of Dyspepsia. The American Journal of Gastroenterology, 112(7), 988-1013.
[4] Cook, D., Heyland, D., Griffith, L., Cook, R., Marshall, J., Pagliarello, J., & Canadian Critical Care Trials Group. (1999). Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Critical Care Medicine, 27(12), 2812-2817.
[5] Ricci, V., Zarrilli, R., & Romano, M. (2007). Helicobacter pylori gamma-glutamyl transpeptidase and its pathogenic role. World Journal of Gastroenterology, 13(35), 4827-4833.
[6] Lanas, A., & Chan, F. K. (2017). Peptic ulcer disease. The Lancet, 390(10094), 613-624.
[7] Cook, D., Heyland, D., Griffith, L., Cook, R., Marshall, J., Pagliarello, J., & Canadian Critical Care Trials Group. (1999). Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Critical Care Medicine, 27(12), 2812-2817.
[8] Sung, J. J., Kuipers, E. J., El-Serag, H. B., & Systematic review: the global incidence and prevalence of peptic ulcer disease. Alimentary Pharmacology & Therapeutics, 29(9), 938-946.
[9] Shiotani, A., Kamada, T., Yerian, L., & el-Zimaity, H. M. (2007). Acid secretion, gastrin release, and mucosal blood flow in the smoking stomach. Journal of Clinical Gastroenterology, 41(5), 487-491.
[10] Graham, D. Y., & El-Omar, E. M. (2008). Helicobacter pylori Infection. New England Journal of Medicine, 359(7), 738–749.
[11] Lanas, A., & Chan, F. K. L. (2017). Peptic ulcer disease. Lancet, 390(10094), 613–624.
[12] Katzung, B. G., Trevor, A. J., & Kruidering-Hall, M. (Eds.). (2021). Basic and Clinical Pharmacology (15th ed.). McGraw-Hill Education.
[13] Konturek, S. J., Konturek, P. C., Brzozowski, T., & Ernst, H. (2004). Helicobacter pylori infection in gastric ulcerogenesis. Journal of Physiology and Pharmacology, 55(Suppl 2), 5–18.
[14] Kopic, S., & Geibel, J. P. (2013). Gastric Acid, Acidification, and Their Impact on Gastric Pathophysiology. Surgical Clinics of North America, 93(3), 516–528.
[15] Menges, M., Müller, M., & Zeitz, M. (1980). Interaction of acid and pepsin with the gastric mucosa. Scandinavian Journal of Gastroenterology, 66, 53–63.
[16] Allen, A., Hutton, D. A., & Leonard, A. J. (1993). Mucin glycoproteins: structure, function, and drug delivery. Advanced Drug Delivery Reviews, 8(3), 167–184.
[17] Malfertheiner, P., Chan, F. K. L., McColl, K. E. L. (2017). Peptic ulcer disease. The Lancet, 390(10094), 613–624.
[18] Talley, N. J., Ford, A. C., & Malagelada, J. R. (2015). Functional dyspepsia. New England Journal of Medicine, 373(19), 1853–1863.
[19] Lanas, A., & Chan, F. K. L. (2017). Peptic ulcer disease. The Lancet, 390(10094), 613–624.
[20] Lanas, A., Chan, F. K., & Peptic Ulcer Bleed Study Group. (2011). Peptic ulcer disease. The Lancet, 378(9800), 173-184.
[21] Lu, C. L., Lang, H. C., Chang, F. Y., Chen, C. Y., Luo, J. C., Wang, S. S., ... & Lee, S. D. (2009). Association between alcoholism and the risk of peptic ulcers: a population-based cohort study. The American Journal of Gastroenterology, 104(3), 721-727.
[22] Ford, A. C., Quigley, E. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., ... & Moayyedi, P. (2018). Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. The American Journal of Gastroenterology, 113(1), 21-37.
[23] Zhang, Y., Qian, J., Zhang, S., Qiao, L., & Huang, Y. (2019). Helicobacter pylori Vaccines: Opportunities and Challenges. World Journal of Gastroenterology, 25(43), 6209–6220.
[24] Lanas, A., Chan, F. K., & Peptic Ulcer Bleed Study Group. (2011). Peptic ulcer disease. The Lancet, 378(9800), 173-184.
[25] Lu, C. L., Lang, H. C., Chang, F. Y., Chen, C. Y., Luo, J. C., Wang, S. S., ... & Lee, S. D. (2009). Association between alcoholism and the risk of peptic ulcers: a population-based cohort study. The American Journal of Gastroenterology, 104(3), 721-727.
[26] Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., ... & Graham, D. Y. (2017). Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut, 66(1), 6-30.
[27] Laine, L., Jensen, D. M., Kovacs, T. O. G., Muthasamy, R., Dumonceau, J. M., Ginsberg, G. G., ... & Zakko, S. (2017). Management of patients with ulcer bleeding. American Journal of Gastroenterology, 112(6), 843-860.
[28] Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., ... & Graham, D. Y. (2017). Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut, 66(1), 6-30.